Evidence map›Paper›PMID 30596671›Full record

ArticlePLoS neglected tropical diseases2018

A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela.

Aaron F Carlin, Jinsheng Wen, Edward A Vizcarra, Melanie McCauley, Antoine Chaillon, Kevan Akrami, Cheryl Kim, Annie Elong Ngono, Maria Luz Lara-Marquez, Davey M Smith and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Oral lipid prodrug V2043 (1-Antimicrobial agents and chemotherapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. CD8Science advances · 2020
    Article
  6. CD4Cell reports · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Aaron F CarlinDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0002-1669-8066
Jinsheng WenDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Edward A VizcarraDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Melanie McCauleyDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Antoine ChaillonDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Kevan AkramiDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Cheryl KimDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Annie Elong NgonoDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, California, United States of America.
Maria Luz Lara-MarquezDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Davey M SmithDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Christopher K GlassDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Robert T SchooleyDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Christopher BennerDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Sujan ShrestaDepartment of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
University of California San Diego · USLa Jolla Institute for Immunology · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
IRF-3/5/7-Independent Antiviral ImmunityR01AI116813 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SHRESTA, SUJAN · 2016 to 2019
$1.9M
Vaginal Adaptive Immunity Against Zika VirusR21AI140063 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SHRESTA, SUJAN · 2018 to 2019
$495k
NCATS NIH HHS KL2 TR001444NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI116813NIAID NIH HHS R21 AI140063
6 · The paper itself

Abstract

Zika virus (ZIKV) is an emerging mosquito-borne flavivirus linked to devastating neurologic diseases. Immune responses to flaviviruses may be pathogenic or protective. Our understanding of human immune responses to ZIKV in vivo remains limited. Therefore, we performed a longitudinal molecular and phenotypic characterization of innate and adaptive immune responses during an acute ZIKV infection. We found that innate immune transcriptional and genomic responses were both cell type- and time-dependent. While interferon stimulated gene induction was common to all innate immune cells, the upregulation of important inflammatory cytokine genes was primarily limited to monocyte subsets. Additionally, genomic analysis revealed substantial chromatin remodeling at sites containing cell-type specific transcription factor binding motifs that may explain the observed changes in gene expression. In this dengue virus-experienced individual, adaptive immune responses were rapidly mobilized with T cell transcriptional activity and ZIKV neutralizing antibody responses peaking 6 days after the onset of symptoms. Collectively this study characterizes the development and resolution of an in vivo human immune response to acute ZIKV infection in an individual with pre-existing flavivirus immunity.

Indexed as

Acute DiseaseAdaptive ImmunityAdultAntibodies, ViralChromatinCytokinesFemaleHumansLongitudinal StudiesPhylogenyT-LymphocytesTravelVenezuelaZika VirusZika Virus InfectionAntibodies, ViralChromatinCytokines

Identifiers

PMID30596671
PMCPMC6329527
OpenAlexW2907968062

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.